It will contribute to a better approach to cancer disease based on personalized medicine practices
Read moreThe outstanding ability of tardigrades to survive environmental extremes has attracted an enormous attention in biology and biotechnology
Read moreOncoDNA SA has become the first shareholder of IntegraGen SA (Paris: ALINT), holding 29.99% of the existing shares, as result of purchases of shares on the Euronext Growth market .
Read moreRecent studies have found that some human cancer cells display a mutation bias where DNA that directly codes for proteins mutates at a different rate compared to DNA sequences which do not. It was hyp...
Read morePatients with this syndrome have more mutations in the microsatellite regions of the genome. The detection of these mutations improves the diagnosis and therapeutic management of patients.
Read moreWhen nucleotide levels drop, a common step during initiation of aggressive cancers, ribosomes biogenesis detects it and prevent DNA replication, as this could lead to genome damage.
Read moreThe link between obesity and other diseases may be found in chromosomal inversions
Read moreVETGENOMICS, SL company, an international leader in diagnosis and research in "One Health" with expertise in genomics, pathogens and microbiome has obtained the American grant of the patent "METHODS F...
Read moreTelomerase is an enzyme that actively participates in the lengthening of telomeres by partly recovering the DNA that is destroyed in each cell division.
Read moreThe new groups, led by researchers Felipe Cortés, Eva González-Suárez and Solip Park, join the more than 400 scientists who make up the Center to boost the basic and translational Molecular Oncolog...
Read moreOncoDNA, a company which specialises in precision medicine for the treatment and diagnosis of cancer, has participated in a pioneering study on the usefulness and impact of molecular profiling in canc...
Read moreOncoDNA adds the analysis of germinal DNA, a crucial marker in the management of ovarian, prostate, pancreas and triple-negative breast cancers
Read more